Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Cell Reports|January 9, 2020
CD4<sup>+</sup> T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4<sup>+</sup> CellsElena Brenna, Alexey N Davydov, Kristin Ladell, et al.
Science Advances|June 25, 2020
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaquesNeeltje van Doremalen, Elaine Haddock, Friederike Feldmann, et al.
NPJ Vaccines|March 3, 2021
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challengeRobert J Fischer, Jyothi N Purushotham, Neeltje van Doremalen, et al.
NPJ Vaccines|February 15, 2023
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigsEleni Vatzia, Katherine Feest, Adam McNee, et al.
NPJ Vaccines|December 21, 2022
ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeysNeeltje van Doremalen, Victoria A Avanzato, Kerry Goldin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2010
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccinesSimon J Draper, Sumi Biswas, Alexandra J Spencer, et al.
Vaccine|May 4, 2019
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact componentsSofiya Fedosyuk, Thomas Merritt, Marco Polo Peralta-Alvarez, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Nature Communications|September 23, 2018
A naturally protective epitope of limited variability as an influenza vaccine targetCraig P Thompson, José Lourenço, Adam A Walters, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Cell Reports|January 9, 2020
CD4<sup>+</sup> T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4<sup>+</sup> CellsElena Brenna, Alexey N Davydov, Kristin Ladell, et al.
Science Advances|June 25, 2020
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaquesNeeltje van Doremalen, Elaine Haddock, Friederike Feldmann, et al.
NPJ Vaccines|March 3, 2021
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challengeRobert J Fischer, Jyothi N Purushotham, Neeltje van Doremalen, et al.
NPJ Vaccines|February 15, 2023
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigsEleni Vatzia, Katherine Feest, Adam McNee, et al.
NPJ Vaccines|December 21, 2022
ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeysNeeltje van Doremalen, Victoria A Avanzato, Kerry Goldin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2010
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccinesSimon J Draper, Sumi Biswas, Alexandra J Spencer, et al.
Vaccine|May 4, 2019
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact componentsSofiya Fedosyuk, Thomas Merritt, Marco Polo Peralta-Alvarez, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
Vaccines|June 25, 2026
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency ResponseMarco Polo Peralta Alvarez, Shawkat Hussain, Andrea Magri, et al.
Nature Communications|September 23, 2018
A naturally protective epitope of limited variability as an influenza vaccine targetCraig P Thompson, José Lourenço, Adam A Walters, et al.
Pageof 22